Mandelboim O - Search Results

1

Derivation and Preclinical Characterization of CYT-303, a Novel NKp46-NK Cell Engager Targeting GPC3.

Arulanandam A, Lin L, Chang HM, Cerutti M, Choblet S, Gao P, Rath A, Bensussan A, Kadouche J, Teper D, Mandelboim O, Li W. Arulanandam A, et al. Among authors: mandelboim o. Cells. 2023 Mar 24;12(7):996. doi: 10.3390/cells12070996. Cells. 2023. PMID: 37048069 Free PMC article.

2

NKp46.

Mandelboim O, Porgador A. Mandelboim O, et al. Int J Biochem Cell Biol. 2001 Dec;33(12):1147-50. doi: 10.1016/s1357-2725(01)00078-4. Int J Biochem Cell Biol. 2001. PMID: 11606250 Review.

3

Enhanced in vivo growth of lymphoma tumors in the absence of the NK-activating receptor NKp46/NCR1.

Halfteck GG, Elboim M, Gur C, Achdout H, Ghadially H, Mandelboim O. Halfteck GG, et al. Among authors: mandelboim o. J Immunol. 2009 Feb 15;182(4):2221-30. doi: 10.4049/jimmunol.0801878. J Immunol. 2009. PMID: 19201876

4

The activating receptor NKp46 is essential for the development of type 1 diabetes.

Gur C, Porgador A, Elboim M, Gazit R, Mizrahi S, Stern-Ginossar N, Achdout H, Ghadially H, Dor Y, Nir T, Doviner V, Hershkovitz O, Mendelson M, Naparstek Y, Mandelboim O. Gur C, et al. Among authors: mandelboim o. Nat Immunol. 2010 Feb;11(2):121-8. doi: 10.1038/ni.1834. Epub 2009 Dec 20. Nat Immunol. 2010. PMID: 20023661

5

Tumor immunoediting by NKp46.

Elboim M, Gazit R, Gur C, Ghadially H, Betser-Cohen G, Mandelboim O. Elboim M, et al. Among authors: mandelboim o. J Immunol. 2010 May 15;184(10):5637-44. doi: 10.4049/jimmunol.0901644. Epub 2010 Apr 19. J Immunol. 2010. PMID: 20404273

6

Paired NK cell receptors controlling NK cytotoxicity.

Stanietsky N, Mandelboim O. Stanietsky N, et al. Among authors: mandelboim o. FEBS Lett. 2010 Dec 15;584(24):4895-900. doi: 10.1016/j.febslet.2010.08.047. Epub 2010 Sep 7. FEBS Lett. 2010. PMID: 20828570 Free article. Review.

7

Recognition and killing of human and murine pancreatic beta cells by the NK receptor NKp46.

Gur C, Enk J, Kassem SA, Suissa Y, Magenheim J, Stolovich-Rain M, Nir T, Achdout H, Glaser B, Shapiro J, Naparstek Y, Porgador A, Dor Y, Mandelboim O. Gur C, et al. Among authors: mandelboim o. J Immunol. 2011 Sep 15;187(6):3096-103. doi: 10.4049/jimmunol.1101269. Epub 2011 Aug 17. J Immunol. 2011. PMID: 21849674

8

Recognition and prevention of tumor metastasis by the NK receptor NKp46/NCR1.

Glasner A, Ghadially H, Gur C, Stanietsky N, Tsukerman P, Enk J, Mandelboim O. Glasner A, et al. Among authors: mandelboim o. J Immunol. 2012 Mar 15;188(6):2509-15. doi: 10.4049/jimmunol.1102461. Epub 2012 Feb 3. J Immunol. 2012. PMID: 22308311

9

NKp46 regulates allergic responses.

Ghadially H, Horani A, Glasner A, Elboim M, Gazit R, Shoseyov D, Mandelboim O. Ghadially H, et al. Among authors: mandelboim o. Eur J Immunol. 2013 Nov;43(11):3006-16. doi: 10.1002/eji.201343388. Epub 2013 Aug 21. Eur J Immunol. 2013. PMID: 23878025 Free PMC article.

10

The expression of the beta cell-derived autoimmune ligand for the killer receptor nkp46 is attenuated in type 2 diabetes.

Gur C, Enk J, Weitman E, Bachar E, Suissa Y, Cohen G, Schyr RB, Sabanay H, Horwitz E, Glaser B, Dor Y, Pribluda A, Hanna JH, Leibowitz G, Mandelboim O. Gur C, et al. Among authors: mandelboim o. PLoS One. 2013 Aug 29;8(8):e74033. doi: 10.1371/journal.pone.0074033. eCollection 2013. PLoS One. 2013. PMID: 24009765 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

257 results

Search Page